CA
CELU icon

CoreCap Advisors’s Celularity CELU Stock Holding History

CoreCap Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299 Hold
500
– – ﹤0.01% 2947
2026
Q1 		$665 Hold
500
– – ﹤0.01% 2604
2025
Q4 		$555 Hold
500
– – ﹤0.01% 2690
2025
Q3 		$1.03K Hold
500
– – ﹤0.01% 2479
2025
Q2 		$980 Hold
500
– – ﹤0.01% 2421
2025
Q1 		$865 Hold
500
– – ﹤0.01% 2556
2024
Q4 		$1.04K Hold
500
– – ﹤0.01% 2369
2024
Q3 		$1.49K Buy
+500
New +$1.47K ﹤0.01% 2222
2024
Q2 		– Sell
-500
Closed -$2.62K – 1762
2024
Q1 		$2.62K Buy
+500
New +$2.06K ﹤0.01% 2066

Other funds holding CELU

HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
KFS
Keynote Financial Services Vernon, Connecticut $214M AUM 60.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WCM
Weaver Capital Management Suwanee, Georgia $454M AUM 20.18% 1-Year Est. Return
FP
Financial Perspectives Minneapolis, Minnesota $411M AUM 26.27% 1-Year Est. Return
VNA
Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return

CoreCap Advisors's CELU Position: Q2 2026 in Review

CoreCap Advisors held its Celularity (CELU) position steady in Q2 2026 at 500 shares worth $299. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

CoreCap Advisors first reported a position in CELU in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.62K in Q1 2024. 8 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • CoreCap Advisors held 500 shares of Celularity worth $299 as of Q2 2026.
  • CoreCap Advisors left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2947 holding.
  • CoreCap Advisors first reported a position in Celularity in Q1 2024 and has held it in 9 quarters since.
  • CoreCap Advisors's Celularity position peaked at $2.62K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.